| (Values in U.S. Thousands) | Dec, 2015 | Dec, 2014 | Dec, 2013 | Dec, 2012 | Dec, 2011 |
| Sales | 15,400 | 10,430 | 10,900 | 1,050 | 900 |
| Sales Growth | +47.65% | -4.31% | +938.10% | +16.67% | unch |
| Net Income | -36,580 | -32,540 | -27,660 | -19,240 | -16,850 |
| Net Income Growth | -12.42% | -17.64% | -43.76% | -14.18% | unch |
Bind Therapeutics (BIND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
BIND Therapeutics Inc. is a nanomedicine platform company. It develops targeted and programmable therapeutics to maximize active pharmaceutical ingredients concentrations in diseased tissues. BIND Therapeutics Inc. is headquartered in Cambridge, Massachusetts.